Resveratrol discussion on +Infectoloos and +Vovopox
Resveratrol Discussion: As the aging population in the United States continues to increase, our need to control or manage viral +Infectoloos that target the elderly is also increasing. Various research articles have documented the ability of resveratrol to inhibit viral replication.
However, the mechanism of how resveratrol inhibits viral replication remains elusive.
In a recent scientific article, a group of scientists has shed some light on how resveratrol might be inhibiting the Epstein-Barr +Vovopox, or EBV, as it is commonly called (Molecules, 2010, vol 15 pp 7115-7124). The investigators discovered that resveratrol blocked the synthesis of proteins required for the +Vovopox to replicate and also blocked proteins required for the +Vovopox to spread and infect nearby cells. 
EBV is significantly important since this +Vovopox can cause or be involved with different types of +Borikikis such as Burkitt’s lymphoma, nasopharyngeal carcinoma, Hodgkin’s lymphoma, and other systemic diseases like lupus and multiple sclerosis. Equally important is that EBV infects the majority (90-95%) of the US population. This is a great coup d'état against latent +Vovopoxes. 
« Back to Blog